Related Experiment Video
Updated: Dec 14, 2025

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment
Published on: December 3, 2020
Considerations and Caveats when Applying Global Sensitivity Analysis Methods to Physiologically Based Pharmacokinetic
Dan Liu1, Linzhong Li2, Amin Rostami-Hodjegan2
1Simcyp Division, Certara UK Limited, Level 2-Acero, 1 Concourse Way, Sheffield, S1 2BJ, UK. danliu01@outlook.com.
Global sensitivity analysis (GSA) methods reveal key drug parameters influencing pharmacokinetics (PK). Ignoring parameter correlations can bias results, emphasizing the need for careful interpretation in minimal physiologically based PK (mPBPK) models.
Area of Science:
- Pharmacokinetics and Drug Metabolism
- Computational Biology
- Systems Pharmacology
Background:
- Physiologically based pharmacokinetic (PBPK) models are crucial for predicting drug behavior.
- Global sensitivity analysis (GSA) identifies key model parameters influencing predictions.
- Understanding parameter influence is vital for accurate pharmacokinetic (PK) assessments.
Purpose of the Study:
- To compare three GSA methods (Morris, Sobol, extended Sobol) for a minimal PBPK (mPBPK) model.
- To investigate the impact of input parameter correlations on GSA results.
- To identify key parameters affecting maximal plasma concentration (Cmax), time to Cmax (Tmax), and area under the curve (AUC) for quinidine, alprazolam, and midazolam.
Main Methods:
- Application of Morris, Sobol, and extended Sobol GSA methods to an mPBPK model.
- Analysis of PK outputs: Cmax, Tmax, and AUC24h.
- Comparison of influential parameters identified by methods that do and do not account for parameter correlations.
Main Results:
- Morris and Sobol methods showed comparable informativeness for independent parameters.
- Extended Sobol method, accounting for correlations, identified different influential parameters.
- Overestimation of volume of distribution at steady state (Vss) on AUC24h and underestimation of liver volume (Vliver) were observed.
- Specific enzyme clearance and abundance parameters were also misjudged by certain methods.
Conclusions:
- Interpreting GSA results requires careful consideration of model assumptions and method limitations.
- Ignoring parameter correlations in GSA can lead to biased identification of key PK parameters.
- Decisions on parameter influence should integrate knowledge of model structure, GSA limitations, and parameter inter-correlations.
More Related Videos
Related Concept Videos
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
Pharmacokinetic Models: Overview
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
Model Approaches for Pharmacokinetic Data: Physiological Models
Physiological Pharmacokinetic Models: Assumption with Protein Binding
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...

